Use of N,N-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (DPPE) in cancer therapy

Details for Australian Patent Application No. 2002336840 (hide)

International Classifications

Event Publications

20 February 2003 Complete Application Filed

Priority application(s): 2,360,849 01.11.01 CA

10 July 2003 Application Open to Public Inspection

Published as AU-A-2002336840

1 March 2007 Change of Name(s) of Applicant(s), Section 104

YM Biosciences, Inc. The name of the applicant has been changed to YM Biosciences, Inc.; University of Manitoba 2003

29 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.